Skip to main content
Top
Published in: Supportive Care in Cancer 3/2018

01-03-2018 | Original Article

As if the disease was not enough: coping with the financial consequences of cancer

Authors: Barbara Head, Lesley Harris, Karen Kayser, Amy Martin, Lisa Smith

Published in: Supportive Care in Cancer | Issue 3/2018

Login to get access

Abstract

Purpose

The goal of this research was to understand how cancer survivors cope with the financial consequences of their disease.

Methods

Twenty-six cancer survivors who self-identified as having experienced financial hardship related to their disease were interviewed. Transcripts of these interviews were analyzed using constructivist grounded theory approach. An analysis of codes related to coping strategies was conducted, and findings were stratified based on established coping theories (Lazarus and Folkman and Moos and Holahan) previously applied to coping with serious/chronic illnesses.

Results

Participants used both person-oriented/emotion-focused and task/problem-focused coping skills to confront the financial consequences of their disease trajectory. Problem-focused skills included dealing with debt, accessing financial assistance, making lifestyle changes, seeking information and education, altering treatment protocols, being proactive, and negotiating insurance. Emotion-focused tasks included using personal strengths, expressing emotion, accessing social support, being determined, and taking care of oneself. Results were further analyzed using Moos and Holahan’s framework of coping skills; examples of each of these coping skills were identified in the interview data.

Conclusions

Facing serious financial ramifications due to a cancer diagnosis calls forth coping skills and tasks that can be categorized using coping theories traditionally applied to coping with the illness itself. Cancer patients are often confronted with dual threats: the physical and emotional impact of the illness and the loss of financial security and the lifestyle that they have worked to maintain. Interventions with cancer survivors should include facilitating effective coping with the financial implications of the disease.
Literature
5.
go back to reference Sharp L, Carsin AE, Timmons A (2012) Associations between cancer-related financial stress and strain and psychological well-being among individuals living with cancer. Psycho-Oncology 22:745–755CrossRefPubMed Sharp L, Carsin AE, Timmons A (2012) Associations between cancer-related financial stress and strain and psychological well-being among individuals living with cancer. Psycho-Oncology 22:745–755CrossRefPubMed
6.
go back to reference Himmelstein DU, Thorne D, Warren E, Woolhandler S (2009) Medical bankruptcy in the United States, 2007: results of a national study. Am J Med 122(8):741–746CrossRefPubMed Himmelstein DU, Thorne D, Warren E, Woolhandler S (2009) Medical bankruptcy in the United States, 2007: results of a national study. Am J Med 122(8):741–746CrossRefPubMed
7.
go back to reference Kim H, Yoon W, Zurlo KA (2012) Health shocks, out-of-pocket medical expenses and consumer debt among middle-aged and older Americans. J Consum Aff 46(3):357–380CrossRef Kim H, Yoon W, Zurlo KA (2012) Health shocks, out-of-pocket medical expenses and consumer debt among middle-aged and older Americans. J Consum Aff 46(3):357–380CrossRef
8.
go back to reference Shankaran V, Jolly S, Blough D, Ramsey SD (2012) Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer. Popul-Based Explor Anal J Clin Oncol 30(14):1608–1614 Shankaran V, Jolly S, Blough D, Ramsey SD (2012) Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer. Popul-Based Explor Anal J Clin Oncol 30(14):1608–1614
9.
go back to reference Amir Z, Wilson K, Hennings J, Young A (2012) The meaning of cancer: implications for family finances and consequent impact on lifestyle, activities, roles and relationships. Psycho-Oncology 21:1167–1174CrossRefPubMed Amir Z, Wilson K, Hennings J, Young A (2012) The meaning of cancer: implications for family finances and consequent impact on lifestyle, activities, roles and relationships. Psycho-Oncology 21:1167–1174CrossRefPubMed
11.
go back to reference Zafar S, Peppercorn JM, Schrag D (2013) The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient’s experience. Oncologist 18(4):381–390CrossRefPubMedPubMedCentral Zafar S, Peppercorn JM, Schrag D (2013) The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient’s experience. Oncologist 18(4):381–390CrossRefPubMedPubMedCentral
12.
go back to reference Wagner L, Lacey MD (2003) The hidden costs of cancer care: an overview with implications and referral resources for oncology nurses. Clin J Oncol Nurs 8(3):279–286CrossRef Wagner L, Lacey MD (2003) The hidden costs of cancer care: an overview with implications and referral resources for oncology nurses. Clin J Oncol Nurs 8(3):279–286CrossRef
13.
go back to reference National Patient Advocate Foundation (2014) Medical debt, medical bankruptcy and the impact on patients. National Patient Advocate Foundation, Washington, D.C. National Patient Advocate Foundation (2014) Medical debt, medical bankruptcy and the impact on patients. National Patient Advocate Foundation, Washington, D.C.
14.
go back to reference Timmons A, Gooberman-Hill R, Sharp L (2013) “It’s at a time in your life when you are most vulnerable”: a qualitative exploration of the financial impact of a cancer diagnosis and implications for financial protection in health. PLoS One 8(11):e77549CrossRefPubMedPubMedCentral Timmons A, Gooberman-Hill R, Sharp L (2013) “It’s at a time in your life when you are most vulnerable”: a qualitative exploration of the financial impact of a cancer diagnosis and implications for financial protection in health. PLoS One 8(11):e77549CrossRefPubMedPubMedCentral
15.
go back to reference Bradley S, Sherwood PR, Donovan HS, Hamilton R, Rosenzweig M, Hricik A, Newberry A, Bender C (2007) I could lose everything: understanding the cost of a brain tumor. J Neurooncol 85:329–338CrossRefPubMed Bradley S, Sherwood PR, Donovan HS, Hamilton R, Rosenzweig M, Hricik A, Newberry A, Bender C (2007) I could lose everything: understanding the cost of a brain tumor. J Neurooncol 85:329–338CrossRefPubMed
16.
go back to reference Lazarus RS, Folkman S (1984) Stress, appraisal, and coping. Springer, New York Lazarus RS, Folkman S (1984) Stress, appraisal, and coping. Springer, New York
17.
go back to reference Larsen PD, Hummel FI (2009) Adaptation. In: Lubkin IM, Larsen PD (eds) Chronic illness: impact and intervention. Seventh edn. jones and Bartlett Boston, pp 67–81 Larsen PD, Hummel FI (2009) Adaptation. In: Lubkin IM, Larsen PD (eds) Chronic illness: impact and intervention. Seventh edn. jones and Bartlett Boston, pp 67–81
18.
go back to reference Folkman S, Moskowitz JT, Ozer EM, Park CL (1997) Positive meaningful events and coping in the context of HIV/AIDS. In: Gottlieb BH (ed) Coping with chronic stress. Plenum, New York, pp 293–314CrossRef Folkman S, Moskowitz JT, Ozer EM, Park CL (1997) Positive meaningful events and coping in the context of HIV/AIDS. In: Gottlieb BH (ed) Coping with chronic stress. Plenum, New York, pp 293–314CrossRef
19.
go back to reference Shim M, Kollar LMM, Roberts L, Gustafson D (2015) Communication competence, psychological well-being, and the mediating role of coping efforts among women with breast cancer: cross-sectional and longitudinal experience. Women Health 55(4):400–418CrossRefPubMedPubMedCentral Shim M, Kollar LMM, Roberts L, Gustafson D (2015) Communication competence, psychological well-being, and the mediating role of coping efforts among women with breast cancer: cross-sectional and longitudinal experience. Women Health 55(4):400–418CrossRefPubMedPubMedCentral
20.
go back to reference Moos RH, Holahan CJ (2007) Adaptive tasks and methods of coping with illness and disability. In: Martz E, Livneh H (eds) Coping with chronic illness and disability. Springer, New York, pp 107–128CrossRef Moos RH, Holahan CJ (2007) Adaptive tasks and methods of coping with illness and disability. In: Martz E, Livneh H (eds) Coping with chronic illness and disability. Springer, New York, pp 107–128CrossRef
21.
go back to reference De Souza JA, Yap BJ, Hlubocky FJ, Wroblewski K, Ratain MJ, Cella DF, Daugherty CK (2014) The development of a financial toxicity patient-reported outcome in cancer: the COST measure. Cancer (0008543X) 120(20):3245–3253CrossRef De Souza JA, Yap BJ, Hlubocky FJ, Wroblewski K, Ratain MJ, Cella DF, Daugherty CK (2014) The development of a financial toxicity patient-reported outcome in cancer: the COST measure. Cancer (0008543X) 120(20):3245–3253CrossRef
22.
go back to reference De Souza JA, Yap BJ, Wroblewski K, Blinder V, Araujo FS, 516 Hlubocky FJ, Nicholas LH, O’Connor JM, Brockstein B, Ratain 517 MJ, Daugherty CK, Cella DF (2017) Measuriing financial toxicity as a clinically relevant patient-reported outcome: the validation of the Comprehensive Score for financial Toxicity. Cancer 123(3): 476–484 De Souza JA, Yap BJ, Wroblewski K, Blinder V, Araujo FS, 516 Hlubocky FJ, Nicholas LH, O’Connor JM, Brockstein B, Ratain 517 MJ, Daugherty CK, Cella DF (2017) Measuriing financial toxicity as a clinically relevant patient-reported outcome: the validation of the Comprehensive Score for financial Toxicity. Cancer 123(3): 476–484
23.
go back to reference Charmaz K (2014) Constructing grounded theory: a practical guide through qualitative analysis. Sage, London Charmaz K (2014) Constructing grounded theory: a practical guide through qualitative analysis. Sage, London
25.
go back to reference Cohen J (1960) A coefficient of agreement for nominal scales. Educ Psychol Meas 20(1):37–46CrossRef Cohen J (1960) A coefficient of agreement for nominal scales. Educ Psychol Meas 20(1):37–46CrossRef
26.
go back to reference De Vries H, Elliot MN, Kanouse DE, Teleki SS (2008) Using pooled kappa to summarize interrater agreement across many items. Field Methods 20(3):272–282CrossRef De Vries H, Elliot MN, Kanouse DE, Teleki SS (2008) Using pooled kappa to summarize interrater agreement across many items. Field Methods 20(3):272–282CrossRef
27.
go back to reference Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33(1): 159–174. Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33(1): 159–174.
28.
go back to reference Corbin J, Strauss A (2014) Basics of qualitative research: techniques and procedures for developing grounded theory. Sage, Thousand Oaks, CA Corbin J, Strauss A (2014) Basics of qualitative research: techniques and procedures for developing grounded theory. Sage, Thousand Oaks, CA
29.
go back to reference Franks HM, Roesch SC (2006) Appraisals and coping in people living with cancer: a meta-analysis. Psycho-Oncology 15(12):1027–1037 1011CrossRefPubMed Franks HM, Roesch SC (2006) Appraisals and coping in people living with cancer: a meta-analysis. Psycho-Oncology 15(12):1027–1037 1011CrossRefPubMed
30.
go back to reference Thomson TG, Rydahl-Hansen S, Wagner L (2010) A review of potential factors relevant to coping in patients with advanced cancer. J Clin Nurs 19:3410–3426CrossRef Thomson TG, Rydahl-Hansen S, Wagner L (2010) A review of potential factors relevant to coping in patients with advanced cancer. J Clin Nurs 19:3410–3426CrossRef
Metadata
Title
As if the disease was not enough: coping with the financial consequences of cancer
Authors
Barbara Head
Lesley Harris
Karen Kayser
Amy Martin
Lisa Smith
Publication date
01-03-2018
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 3/2018
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-017-3918-y

Other articles of this Issue 3/2018

Supportive Care in Cancer 3/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine